BioCryst Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $4.5M | 597k | 7.60 |
| 2024-06-30 | $4.8M | 776k | 6.18 |
| 2024-03-31 | $3.5M | 690k | 5.08 |
| 2023-12-31 | $4.5M | 752k | 5.99 |
| 2023-09-30 | $5.4M | 768k | 7.08 |
| 2023-06-30 | $5.3M | 760k | 7.04 |
| 2023-03-31 | $5.6M | 671k | 8.34 |
| 2022-12-31 | $7.8M | 677k | 11.48 |
| 2022-09-30 | $14M | 671k | 20.83 |
| 2022-06-30 | $6.6M | 620k | 10.58 |
| 2022-03-31 | $15M | 892k | 16.26 |
| 2021-12-31 | $12M | 858k | 13.85 |
| 2021-09-30 | $11M | 748k | 14.37 |
| 2021-06-30 | $12M | 738k | 15.81 |
| 2021-03-31 | $7.3M | 715k | 10.17 |
| 2020-12-31 | $5.6M | 758k | 7.45 |
| 2020-09-30 | $2.5M | 726k | 3.44 |
| 2020-06-30 | $4.0M | 831k | 4.76 |
| 2020-03-31 | $1.3M | 651k | 2.00 |
| 2019-12-31 | $1.9M | 544k | 3.45 |
| 2019-09-30 | $1.2M | 435k | 2.87 |
| 2019-06-30 | $1.7M | 452k | 3.79 |
| 2019-03-31 | $7.3M | 903k | 8.14 |
| 2018-12-31 | $4.4M | 543k | 8.07 |
| 2018-09-30 | $3.2M | 421k | 7.63 |
| 2018-06-30 | $2.3M | 408k | 5.73 |
| 2018-03-31 | $2.2M | 462k | 4.77 |
| 2017-12-31 | $2.3M | 464k | 4.91 |
| 2017-06-30 | $2.1M | 370k | 5.56 |
| 2017-03-31 | $3.0M | 361k | 8.40 |
| 2016-12-31 | $2.1M | 338k | 6.33 |
| 2016-09-30 | $1.4M | 319k | 4.41 |
| 2016-06-30 | $868k | 307k | 2.83 |